Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benbadis, S. R.
Right arrow Articles by Gieron, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benbadis, S. R.
Right arrow Articles by Gieron, M.
Related Collections
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs
Right arrow Generalized seizures
Right arrow Absence seizures
NEUROLOGY 2003;61:1793-1795
© 2003 American Academy of Neurology
Brief Communications

Idiopathic generalized epilepsy and choice of antiepileptic drugs

Selim R. Benbadis, MD, William O. Tatum, IV, DO and Maria Gieron, MD

From the Comprehensive Epilepsy Program, Departments of Neurology (Drs. Benbadis, Tatum, and Gieron), Neurosurgery (Dr. Benbadis), and Pediatrics (Dr. Gieron), University of South Florida and Tampa General Hospital, Tampa, FL.

Address correspondence and reprint requests to Dr. S.R. Benbadis, 4 Columbia Dr., Suite 730, Tampa, FL 33606; e-mail: sbenbadi{at}hsc.usf.edu

The authors reviewed 58 patients with EEG-confirmed idiopathic generalized epilepsy (IGE). When initially seen, 17 (29%) were on broad-spectrum (adequate) antiepileptic drugs (AED) only, 28 (48%) on ill-advised AED only, and 13 (22%) on a combination of both. Thus, a majority of patients with IGE initially receive ill-advised AED, which cause IGE to appear intractable.

Received May 13, 2003. Accepted in final form August 27, 2003.




This article has been cited by other articles:


Home page
 NeurologyHome page
S. F. Berkovic, R. C. Knowlton, R. F. Leroy, J. Schiemann, U. Falter, and On behalf of the Levetiracetam N01057 Study Group
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
Neurology, October 30, 2007; 69(18): 1751 - 1760.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. A. French and R. J. Kryscio
Active control trials for epilepsy: Avoiding bias in head-to-head trials
Neurology, May 9, 2006; 66(9): 1294 - 1295.
[Full Text] [PDF]

Home page
 BrainHome page
P. Thomas, L. Valton, and P. Genton
Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy
Brain, May 1, 2006; 129(5): 1281 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Sankar
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.